Company news

GoodRx Holdings, Inc. news in 2024

GoodRx Holdings, Inc.'s news releases, calls and decks from 2024, newest first.

View company

GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

December 17, 2024

GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties

December 16, 2024

GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer

December 15, 2024

GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged

December 4, 2024

GoodRx Reports Third Quarter 2024 Results

November 6, 2024

GoodRx to Participate in Upcoming Investor Conferences

November 3, 2024

GoodRx Unveils New E-commerce Platform, Launches with Opill®

October 30, 2024

GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults

October 28, 2024

Ronald E. Bruehlman Joins GoodRx Board of Directors

October 27, 2024

GoodRx Announces New Affordability Programs for Menopause Hormone Therapies

October 22, 2024

GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers

October 15, 2024

GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call

October 9, 2024

GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)

September 25, 2024

GoodRx Reports Second Quarter 2024 Results

August 7, 2024

Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira®

July 17, 2024

GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call

July 10, 2024

Ian T. Clark Joins GoodRx Board of Directors

July 9, 2024

GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.

June 25, 2024

Simon Patterson Joins GoodRx Board of Directors

May 29, 2024

GoodRx Named One of the 2024 TIME100 Most Influential Companies

May 29, 2024

GoodRx Offers Discounts of Up to 43% On Fertility Treatments

May 21, 2024

GoodRx and Kroger Sign Direct Contracting Agreement

May 14, 2024

GoodRx Reports First Quarter 2024 Results

May 8, 2024

GoodRx Announces Date for 2024 Investor Day

April 23, 2024

GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call

April 10, 2024

GoodRx Interim CEO Extends Commitment to Company

March 13, 2024

GoodRx Reports Fourth Quarter and Full Year 2023 Results

February 28, 2024

GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call

January 31, 2024

GoodRx Announces Proposed Refinancing of First Lien Credit Facilities

January 21, 2024

The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings

January 10, 2024

GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024

January 9, 2024

Calls in 2024